수의 정형외과 의료 시장 보고서(2026년)
Veterinary Orthopedic Medicine Global Market Report 2026
상품코드 : 1938740
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,691,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,672,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,652,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수의 정형외과 의료 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 40억 3,000만 달러에서 2026년에는 44억 달러로, CAGR 9.1%로 성장이 전망되고 있습니다. 지금까지의 성장 요인으로는 높은 골관절염 및 관절질환 발생률, 반려동물 증가, 초기 단계의 고급 정형외과 치료의 제한적인 보급 상황, 말과 반려견의 스포츠 활동 확대, 동물병원 및 진료소 확충 등을 들 수 있습니다.

수의 정형외과 의료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 59억 9,000만 달러에 달하며, CAGR은 8.0%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 PRP(혈소판풍부혈장) 치료 및 줄기세포 치료의 발전, 점탄성 보충제 및 NSAIDs(비스테로이드성 항염증약)의 사용 증가, 첨단 수술 기술의 채택, 수의 정형외과 연구에 대한 투자 확대, 동물의 운동 기능과 삶의 질에 대한 인식 증가 등을 들 수 있습니다. 예측 기간 중 주요 동향으로는 동물의 근골격계 질환 유병률 증가, 최소침습 정형외과수술의 보급 확대, 줄기세포 및 생물제제 기반 치료법의 성장, 수의학 재활 및 물리치료 서비스 확대, 통증 관리 및 수술 후 회복에 대한 강조 등이 있습니다.

반려동물의 정형외과 질환 발생률 증가는 향후 수년간 수의 정형외과 의료 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물의 정형외과적 질환이란 반려동물(특히 개와 고양이)의 근골격계에 영향을 미치는 병을 말합니다. 이러한 병태 증가는 품종 관련 소인, 비만율 증가, 운동 부족 및 영양 부족과 같은 환경적 요인과 관련이 있습니다. 수의 정형외과 의료는 반려동물의 정형외과 질환의 진단, 치료, 관리에 필수적이며, 통증 완화, 운동성 회복, 삶의 질 향상에 기여합니다. 예를 들어 2024년 7월 미국 비영리단체인 모리스 동물 재단이 발표한 보고서에 따르면 미국에서는 1,400만 마리 이상의 성견이 골관절염을 앓고 있는 것으로 보고되었습니다. 또한 12세 이상 고양이의 약 90%가 엑스레이 검사에서 골관절염의 징후를 보인다는 데이터는 고령 반려동물에서 이 질환의 광범위한 특성을 강조하며, 인식 개선과 첨단 치료법에 대한 필요성이 증가하고 있음을 보여줍니다. 따라서 반려동물의 정형외과 질환 발생률 증가가 수의 정형외과 의료 시장의 성장에 기여하고 있습니다.

수의 정형외과 의료 시장에서 활동하는 주요 기업은 맞춤형 임플란트를 위한 3D 프린팅 연구소, 줄기세포 및 혈소판풍부혈장(PRP) 요법을 포함한 재생의료 접근법, 동물 환자를 위해 특별히 설계된 MRI 및 CT 스캔과 같은 첨단 영상 진단 기술 등 첨단 기술에 대한 투자를 확대하고 있습니다. 확대하고 있습니다. 반려동물 정형외과용 3D 프린팅 연구소란 3D 프린팅 기술을 응용하여 반려동물 정형외과수술용 맞춤형 임플란트, 의족, 수술기구를 제작하는 전문 시설입니다. 예를 들어 2024년 10월, 미국에 본사를 둔 동물 의료 서비스 프로바이더인 VCA 애니멀 호스피털즈(VCA Animal Hospitals)는 오리건주 클라카마스에 위치한 VCA 노스웨스트 동물 전문 병원 시설 내에 3D 프린팅 연구소를 개설했습니다. 이 연구실에서는 첨단 3D 프린팅 기술을 활용하여 각 동물의 고유한 해부학적 구조에 기반한 맞춤형 임플란트 및 수술 가이드를 개발함으로써 반려동물의 정형외과수술을 개선하기 위해 노력하고 있습니다. 골관절염은 1세 이상 반려견의 약 20%, 8세 이상 반려견의 약 80%가 앓고 있으며, 많은 경우 외과적 수술이 필요합니다. VCA는 이러한 개별화된 접근 방식을 통해 기존 방식에 비해 복잡한 정형외과적 질환을 효과적으로 치료하고, 보다 빠른 회복과 우수한 수술 결과를 목표로 하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Veterinary orthopedic medicine constitutes a distinct discipline within veterinary practice, concentrating on the identification, management, and prevention of musculoskeletal disorders and injuries in animals. This field encompasses a spectrum of conditions, including fractures, arthritis, congenital abnormalities, and soft tissue injuries, and entails diverse treatment modalities such as surgical procedures, physical therapy, and rehabilitation, all aimed at reinstating mobility and function in animals.

The primary products of veterinary orthopedic medicine include biologics, viscosupplements, and pharmaceuticals. Biologics are derived from living cells or organisms and are utilized to treat diseases or injuries in various animal species such as dogs, cats, horses, cattle, pigs, and others. These products find multiple applications, including the management of osteoarthritis, degenerative joint disease, joint inflammation or pain, and more, and are employed by veterinary hospitals, clinics, and other end-users.

Tariffs have impacted the veterinary orthopedic medicine market by increasing the costs of imported biologics, viscosupplements, and pharmaceutical products, affecting production and pricing. Regions such as north america and asia-pacific are most affected due to dependency on imported therapies and surgical equipment. Segments like stem cell therapy, prp, and hyaluronic acid injections have faced cost pressures, while tariffs have encouraged domestic manufacturing and innovation in cost-effective treatment solutions. Overall, tariffs have prompted companies to diversify sourcing and strengthen local supply chains.

The veterinary orthopedic medicine market research report is one of a series of new reports from The Business Research Company that provides veterinary orthopedic medicine market statistics, including veterinary orthopedic medicine industry global market size, regional shares, competitors with a veterinary orthopedic medicine market share, detailed veterinary orthopedic medicine market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary orthopedic medicine industry. This veterinary orthopedic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary orthopedic medicine market size has grown strongly in recent years. It will grow from $4.03 billion in 2025 to $4.4 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to high incidence of osteoarthritis and joint disorders, growth in companion animal population, limited availability of advanced orthopedic treatments in early years, increasing equine and canine sports activities, expansion of veterinary hospitals and clinics.

The veterinary orthopedic medicine market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in prp and stem cell therapies, increasing use of viscosupplements and nsaids, adoption of advanced surgical techniques, growing investment in veterinary orthopedic research, rising awareness of animal mobility and quality of life. Major trends in the forecast period include rising prevalence of musculoskeletal disorders in animals, increasing adoption of minimally invasive orthopedic surgeries, growth in stem cell and biologics-based treatments, expansion of veterinary rehabilitation and physiotherapy services, emphasis on pain management and post-surgery recovery.

The rising incidence of pet orthopedic diseases is anticipated to drive the growth of the veterinary orthopedic medicine market in the coming years. Pet orthopedic diseases are conditions that affect the musculoskeletal system of companion animals, especially dogs and cats. The growing occurrence of these conditions is linked to factors such as breed-related predispositions, increasing obesity levels, and environmental influences including insufficient physical activity and poor nutrition. Veterinary orthopedic medicine is essential for the diagnosis, treatment, and management of orthopedic disorders in pets, helping to reduce pain, restore mobility, and enhance overall quality of life. For example, in July 2024, according to a report published by the Morris Animal Foundation, a U.S.-based non-profit organization, more than 14 million adult dogs in the United States were reported to suffer from osteoarthritis. Additionally, data shows that nearly 90% of cats over the age of 12 display radiographic signs of osteoarthritis, emphasizing the widespread nature of this condition among aging pets and highlighting the increasing need for improved awareness and advanced treatment options. Therefore, the rising incidence of pet orthopedic diseases is contributing to the growth of the veterinary orthopedic medicine market.

Major companies operating in the veterinary orthopedic medicine market are increasingly investing in advanced technologies such as 3D printing laboratories for customized implants, regenerative medicine approaches including stem cell and platelet-rich plasma (PRP) therapies, and sophisticated imaging techniques like MRI and CT scans designed specifically for animal patients. A 3D printing lab for pet orthopedic surgeries is a specialized facility that applies 3D printing technology to produce custom implants, prosthetics, and surgical tools tailored for veterinary orthopedic procedures. For instance, in October 2024, VCA Animal Hospitals, a U.S.-based provider of veterinary care services, launched a 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab leverages advanced 3D printing technology to improve orthopedic surgeries for pets by developing custom implants and surgical guides based on each animal's unique anatomy. Osteoarthritis, which affects approximately 20% of dogs over one year of age and nearly 80% of dogs older than eight years, often requires surgical intervention. Through this personalized approach, VCA aims to support faster recovery and better surgical outcomes, enabling more effective treatment of complex orthopedic conditions compared to conventional methods.

In March 2025, Creative Science, a U.S.-based veterinary medical technology company, acquired Infiniti Medical LLC and its subsidiary Orthomed UK Ltd. for an undisclosed sum. Through this acquisition, Creative Science sought to broaden its veterinary innovation portfolio by strengthening its product range and educational programs in areas such as interventional radiology, cardiology, soft tissue surgery, and orthopedic veterinary care. Infiniti Medical LLC is a U.S.-based veterinary medical technology company focused on the development of advanced veterinary technologies and medical devices.

Major companies operating in the veterinary orthopedic medicine market are Zoetis Inc., Elanco Animal Health, Merck Animal Health, Virbac SA, Ceva Sante Animale, Vetoquinol S.A., Bimeda U.S., American Regent, Hyalogic LLC, BioMedtrix LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Veterinary Orthopedic Implants, Integra LifeSciences, Avante Animal Health, DePuy Synthes Vet, KYON AG, Securos Surgical, Arthrex Vet Systems, INNOPLANT Medizintechnik GmbH, VetWelding AG, Scil Animal Care, Intrauma S.p.A., Aysam Veterinary Orthopedics

North America was the largest region in the veterinary orthopedic medicine market in 2025. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary orthopedic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary orthopedic medicine market includes revenues earned by entities by providing services such as diagnosing, treating, and preventing musculoskeletal disorders and injuries in animals. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary orthopedic medicine market also includes sales of external fixation devices, intramedullary devices, and joint implants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Orthopedic Medicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary orthopedic medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary orthopedic medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary orthopedic medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Veterinary Orthopedic Medicine Market Characteristics

3. Veterinary Orthopedic Medicine Market Supply Chain Analysis

4. Global Veterinary Orthopedic Medicine Market Trends And Strategies

5. Veterinary Orthopedic Medicine Market Analysis Of End Use Industries

6. Veterinary Orthopedic Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Orthopedic Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Veterinary Orthopedic Medicine Total Addressable Market (TAM) Analysis for the Market

9. Veterinary Orthopedic Medicine Market Segmentation

10. Veterinary Orthopedic Medicine Market Regional And Country Analysis

11. Asia-Pacific Veterinary Orthopedic Medicine Market

12. China Veterinary Orthopedic Medicine Market

13. India Veterinary Orthopedic Medicine Market

14. Japan Veterinary Orthopedic Medicine Market

15. Australia Veterinary Orthopedic Medicine Market

16. Indonesia Veterinary Orthopedic Medicine Market

17. South Korea Veterinary Orthopedic Medicine Market

18. Taiwan Veterinary Orthopedic Medicine Market

19. South East Asia Veterinary Orthopedic Medicine Market

20. Western Europe Veterinary Orthopedic Medicine Market

21. UK Veterinary Orthopedic Medicine Market

22. Germany Veterinary Orthopedic Medicine Market

23. France Veterinary Orthopedic Medicine Market

24. Italy Veterinary Orthopedic Medicine Market

25. Spain Veterinary Orthopedic Medicine Market

26. Eastern Europe Veterinary Orthopedic Medicine Market

27. Russia Veterinary Orthopedic Medicine Market

28. North America Veterinary Orthopedic Medicine Market

29. USA Veterinary Orthopedic Medicine Market

30. Canada Veterinary Orthopedic Medicine Market

31. South America Veterinary Orthopedic Medicine Market

32. Brazil Veterinary Orthopedic Medicine Market

33. Middle East Veterinary Orthopedic Medicine Market

34. Africa Veterinary Orthopedic Medicine Market

35. Veterinary Orthopedic Medicine Market Regulatory and Investment Landscape

36. Veterinary Orthopedic Medicine Market Competitive Landscape And Company Profiles

37. Veterinary Orthopedic Medicine Market Other Major And Innovative Companies

38. Global Veterinary Orthopedic Medicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Orthopedic Medicine Market

40. Veterinary Orthopedic Medicine Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기